A/Prof Nicole Goh (Conference Convenor)
A/Prof Nicole Goh is a Respiratory Physician in Melbourne, Australia. She is a graduate of the University of Melbourne and started her respiratory training in Melbourne and finished at the Royal Brompton Hospital in London. She went on to do research at Imperial College in London under the mentorship of Professor Athol Wells and was awarded her PhD, Prognostic evaluation of interstitial lung disease secondary to systemic sclerosis, in 2008. She returned to Melbourne and has been working at the Austin Hospital in Melbourne ever since. A/Prof Goh established and is the director of the Interstitial Lung Diseases (ILD) services at the Austin Hospital, and is also part of the ILD unit at the Alfred Hospital in Melbourne.
Her main research is in the area of ILD, focusing in particular on measures of improving quality of life including the role of pulmonary rehabilitation and supplemental oxygen.
Nicole is the Chair of the Medical and Scientific Research Committee for the Institute for Breathing and Sleep in Melbourne, Chair of the Rare Lung Disease Clinical Advisory Committee for Lung Foundation Australia and is on the Steering Committee of the Australian Idiopathic Pulmonary Fibrosis Registry. She is also on the steering committee of the Pulmonary Fibrosis Australasian Clinical Trials Network and the Translation and Education Support group – both of which are part of the Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF).
Dr Lauren Troy
Royal Prince Alfred Hospital
Dr Lauren Troy has specialist appointments at Royal Prince Alfred Hospital and Chris O’Brien Lifehouse, and is a Senior Clinical Lecturer through the Sydney Medical School. She completed her PhD in exercise and sleep physiology in ILD. Clinical and research interests include ILD, interventional pulmonology, bronchiectasis, respiratory infection and education.
Dr Greg Keir
Princess Alexandra Hospital
Dr Greg Keir is a Respiratory and Sleep Physician at the Princess Alexandra Hospital in Brisbane. His clinical and research interests include Pulmonary Hypertension and ILD, in particular ILD associated with autoimmune diseases.
A/Prof Tamera Corte
University of Sydney
A/Prof Tamera Corte, MD, PhD, is a Consultant Respiratory Physician and Director of Interstitial Lung Disease in the Department of Respiratory Medicine at Royal Prince Alfred Hospital, Associate Professor at the University of Sydney and is the founding Co-Chair of the Australian Idiopathic Pulmonary Fibrosis Registry Steering Committee, Chair of the Australasian ILD Registry, and a member of multiple international task forces for ILD.
A/Prof Corte trained in respiratory medicine at the University of New South Wales in Sydney, Australia. She served as Clinical Fellow in ILD at the Royal Brompton Hospital in London. She earned a Doctor of Philosophy degree in the identification of pulmonary vascular dysfunction in ILD.
She continues her research at Sydney University, where her interests include the ILD as well as pulmonary vascular disease. She is the Chief Investigator on the CRE-PF, which strives to improve and extend the lives of patients living with Pulmonary Fibrosis (PF) through the development of a comprehensive and integrated program of basic and clinical research and education across Australia.
Ms Karen Symons
Karen Symons is the ILD Nurse Specialist at the Alfred Hospital, Melbourne. Her role involves coordination of the ILD outpatient service, multidisciplinary team meetings, patient education, as well as both translational and therapeutic clinical trials in Idiopathic Pulmonary Fibrosis and ILD. She also works for Lung Foundation Australia, and coordinates the Australian Idiopathic Pulmonary Fibrosis Registry for Victoria.
Dr Hubertus Jersmann
Dr Hubertus Jersmann was born in Germany (after the war). He migrated to Australia in the eighties and works as a Respiratory and Sleep Physician at the Royal Adelaide Hospital. Since 2011, he has been visiting Alice Springs Hospital every two months. Dr Jersmann has a special interest in Interventional Pulmonology, in particular treating select cases of severe Chronic Obstructive Pulmonary Disease (COPD) with endobronchial valves to achieve non-surgical lung volume reduction as well as patients with asthma, and remodelling with bronchial thermoplasty to reduce smooth muscle hypertrophy. Dr Jersmann has an MD in human genetics and a PhD in Immunobiology and is a Professor in the School of Medicine, University of Adelaide. He enjoys the mix of treating patients, research in the lab, as well as clinical research and of course, teaching.
A/Prof Samantha Ellis
Assoc Professor Samantha Ellis completed her specialty training in radiology in 1997 at the Royal Melbourne Hospital. This was followed by a 12-month Fellowship at Vancouver General Hospital, Canada in thoracic imaging which consolidated her interest in thoracic imaging, gaining immense experience in this field with particular attention paid to ILD.
She has worked at the The Alfred since 2001 in the subspecialty area of Body Imaging. She is Head of Thoracic Imaging, Co-head of Body Imaging and Radiologist Head-of-Ultrasound. Dr Ellis is the radiology representative on the Australian Idiopathic Pulmonary Fibrosis Registry Steering Committee, member of the Victorian Lung Cancer Registry Steering Committee and executive member of VicSTI and Australian and New Zealand Society of Thoracic Radiology. She takes an active role in thoracic intervention, including oncologic intervention, and teaching thoracic radiology to registrars and nursing staff.
In 2020 she attained an Adjunct Associate Professor position, Department of Surgery, Monash University.
Prof Anne Holland
Prof Anne Holland is Professor of Physiotherapy at Monash University and Alfred Health in Melbourne. Prof Holland’s research program investigates supportive therapies for people with chronic respiratory disease, with a focus on COPD and PF. Her recent clinical trials have tested new models of pulmonary rehabilitation to improve access and uptake, including low cost home-based models and telerehabilitation. She is currently leading a multi-national trial of ambulatory oxygen for people with fibrotic lung disease. Prof Holland is a Chief Investigator for the CRE-PF.
A/Prof Cecilia Prêle
University of Western Australia
A/Prof Prêle is Principal Research Fellow and Acting Head of the Hearing Therapeutics Team at the Ear Science Institute Australia. A/Prof Prêle completed her PhD at University College London in the UK and, following a postdoctoral position at Guy’s and St Thomas’s Hospital and King College London, she moved to Perth in 2002. For the past 18 years her research has focused on understanding the body’s response to damage, specifically on inflammation and the development of fibrosis, and on how to modify the repair process.
A/Prof Prêle has had the opportunity to work across different cell types, organs and tissue and has led National Health and Medical Research Council funded research programs in the area of lung fibrosis. Recently she was recruited to Ear Science Institute Australia where, in addition to her lung research program, she leads a research program aimed at limiting the effects of inflammation and fibrosis in the inner ear and on identifying future treatments for individuals with hearing loss.
Mr John Price
Following a major bushfire in Western Australia in late 2011, John exhibited a dry cough and visited his local GP. A chest X-ray, in early 2012, revealed a diagnosis of IPF. At the time his GP did not have an understanding of the disease and there was no follow up or referral on to a specialist.
Following the decline of John’s brother through late stage IPF, John visited a second GP and was re-diagnosed in late 2015. This resulted in referral to a respiratory specialist and shortly thereafter entry into a clinical trial at the Institute for Respiratory Health in Perth. At the beginning of 2020 John embarked on a second trial at Fiona Stanley Hospital.
In May 2018 John attended a Lung Foundation Australia seminar and since then has become involved in the organisation’s programs including the Rare Lung Disease Consumer Committee and the PF Peer Connect service.
John believes there needs to be significant funding made available for research, patient care, rehabilitation, medical community education and increased community awareness. He says there is much that has been done for lung disease, but there is so much more left to be done.